Workflow
PTC Therapeutics(PTCT)
icon
Search documents
PTC Therapeutics (PTCT) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow
2021-01-20 20:11
PTC 2021 J.P. Morgan Healthcare Conference Stuart W. Peltz, Ph.D., CEO THERAPESTIES Forward Looking Statements 2 This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this release, other than statements of historic fact, are forward-looking statements, including statements with respect to 2021 net product revenue guidance, statements with respect to the 2021 operating expenditure guidance and statements r ...
PTC Therapeutics(PTCT) - 2020 Q3 - Earnings Call Transcript
2020-10-30 06:26
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2020 Earnings Conference Call October 29, 2020 4:30 PM ET Company Participants Lisa Hayes - Vice President Investor Relations Stuart Peltz - Chief Executive Officer Emily Hill - Chief Financial Officer Matt Klein - Chief Development Officer Eric Pauwels - Chief Business Officer Conference Call Participants Eric Joseph - JPMorgan Danielle Brill - Raymond James Vincent Chin - Bernstein Li Watsek - Cantor Joel Beatty - Citi Joseph Thome - Cowen & Company Raju Prasad - Wi ...
PTC Therapeutics(PTCT) - 2020 Q2 - Earnings Call Transcript
2020-08-06 03:43
Call Start: 16:30 January 1, 0000 5:32 PM ET | --- | |----------------------------------------------------------| | | | | | PTC Therapeutics, Inc. (NASDAQ:PTCT) | | Q2 2020 Earnings Conference Call August 5, 2020 16:30 ET | | Company Participants | | Alex Kane - Head, Investor Relations | | Stuart Peltz - Chief Executive Officer | | Emily Hill - Chief Financial Officer | | Matt Klein - Chief Development Officer | | Eric Pauwels - Chief Business Officer | | Conference Call Participants | | | | Robyn Karnausk ...
PTC Therapeutics (PTCT) Investor Presentation - Slideshow
2020-07-24 21:36
Splicing Platform Deep Dive July 24, 2020 Forward Looking Statement 2 This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this presentation, other than statements of historic fact, are forward-looking statements, including statements with respect to future revenue and statements regarding: the future expectations, plans and prospects for PTC, including with respect to the expected timing of clinical tri ...
PTC Therapeutics (PTCT) Presents At Jefferies Virtual Healthcare Conference - Slideshow
2020-06-03 16:58
PTC Therapeutics Jefferies Virtual Healthcare Conference Stuart W. Peltz, Ph.D., CEO Forward looking statement 2 This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this presentation, other than statements of historic fact, are forward-looking statements, including statements with respect to future revenue and statements regarding: the future expectations, plans and prospects for PTC, including with res ...
PTC Therapeutics(PTCT) - 2020 Q1 - Earnings Call Transcript
2020-05-01 17:01
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2020 Earnings Conference Call April 30, 2020 4:30 PM ET Company Participants Alex Kane - Head of Investor Relations Stuart Peltz - Chief Executive Officer Emily Hill - Chief Financial Officer Matthew Klein - Chief Development Officer Eric Pauwels - Chief Business Officer Conference Call Participants Eileen Maysek - Cantor Fitzgerald Tazeen Ahmad - BofA Merrill Lynch Joel Beatty - Citigroup Joseph Thome - Cowen and Company Vincent Chen - Bernstein Peter Kim - Barclays ...
PTC Therapeutics(PTCT) - 2019 Q4 - Earnings Call Presentation
2020-03-04 13:47
Fourth Quarter and Full Year 2019 Financial Results & Corporate Update PTC Therapeutics, Inc. Forward looking statement 2 This presentation contains forward -looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 . All statements contained in this presentation, other than statements of historic fact, are forward-looking statements, including statements with respect to 2020 net product revenue guidance, statements with respect to the 2020 non-GAAP R&D and SG&A expense g ...
PTC Therapeutics(PTCT) - 2019 Q4 - Earnings Call Transcript
2020-03-03 00:40
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2019 Earnings Conference Call March 2, 2020 4:30 PM ET Company Participants Alex Kane - Head of Investor Relations Stuart Peltz - Chief Executive Officer Marcio Souza - Chief Operating Officer Emily Hill - Chief Financial Officer Conference Call Participants Alethia Young - Cantor Fitzgerald Joe Thome - Cowen and Company Martin Auster - Credit Suisse Vincent Chen - Bernstein Robyn Karnauskas - SunTrust Robinson Humphrey Sami Corwin - William Blair Gena Wang - Barclays ...
PTC Therapeutics (PTCT) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
2020-01-16 18:59
PTC 2020 JP Morgan Healthcare Conference Stuart W. Peltz, Ph.D., CEO Forward looking statement 2 This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this presentation, other than statements of historic fact, are forward-looking statements, including statements related to preliminary unaudited 2019 financial information with respect to 2019 net product revenue of Translarna for the treatment of nmDMD and ...